Krop IE, Im SA, Barrios C, Bonnefoi H, et al. Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study. J Clin Oncol 2021 Dec 10:JCO2100896. doi: 10.1200/JCO.21.00896.
PMID: 34890214